Equine G100 antibody and antigen (recombinant protein)
Diagnostic anti-Equine G100 antibodies pairs and antigen for animal health (animal Equine/Horse gastrinoma) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-G100-Ag01 | Equine G100 | $3090.00 |
GMP-EQU-G100-Ab01 | Anti-Equine G100 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-G100-Ab02 | Anti-Equine G100 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-G100-Ab03 | Anti-Equine G100 human monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-G100-Ab04 | Anti-Equine G100 human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-EQU-G100-Ag01 |
Product Name | Equine G100 |
Target/Biomarker | Equine G100 |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine G100 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in G100 level test of animal Equine/Horse with gastrinoma. |
Tag | His | Reconized/Reactive Specics | Equine G100 |
Product description | Recombinant Equine G100 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-G100-Ab01,GMP-EQU-G100-Ab02 |
Target/Biomarker | Equine G100 |
Product Name | Anti-Equine G100 mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine G100 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine G100 antibodies in Equine G100 level test of animal Equine/Horse with gastrinoma. |
Product description | Anti-Equine G100 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine G100 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-G100-Ab03,GMP-EQU-G100-Ab04 |
Target/Biomarker | Equine G100 |
Product Name | Anti-Equine G100 human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Equine G100 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine G100 antibodies in Equine G100 level test of animal Equine/Horse with gastrinoma. |
Product description | Anti-Equine G100 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
As of my last update in April 2023, "G100" does not directly refer to a specific, widely recognized term, biomarker, gene, or protein within equine science or veterinary medicine. The designation "G100" could potentially be related to a specific study, product, or a less commonly known marker that has not been broadly covered in mainstream equine research literature or health discussions.
In the context of equine health and science, there is a continuous exploration of genetic markers, proteins, and other biomolecules that play significant roles in health, disease susceptibility, performance, and other physiological traits in horses. Researchers and veterinarians are particularly interested in identifying and understanding biomarkers and genes that can influence equine health outcomes, including those related to immune response, metabolic disorders, muscle development, and reproductive efficiency.
If "G100" is associated with recent or niche research, a particular product, or a novel discovery in equine health, detailed information would likely be found in specialized scientific journals, conference proceedings, or through academic institutions and research organizations focused on equine studies.
For accurate and comprehensive details on "G100" and its relevance to horses, it would be advisable to consult the latest equine research publications or contact equine science experts and veterinary professionals. These sources could provide the most current insights, especially if "G100" pertains to emerging research findings, innovative health solutions, or specific studies in equine genetics and disease management.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.